{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:42Z","timestamp":1791389082600,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/aps.2015.76","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T05:09:44Z","timestamp":1444626584000},"page":"1367-1376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL\/MpSlac-lpr mice"],"prefix":"10.1038","volume":"36","author":[{"given":"Shang-xue","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"BFaps201576_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.","journal-title":"Arthritis Rheum"},{"key":"BFaps201576_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","volume":"189","author":"OT Chan","year":"1999","unstructured":"Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ . A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189: 1639\u201348.","journal-title":"J Exp Med"},{"key":"BFaps201576_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1189\/jlb.0904536","volume":"78","author":"D Bonardelle","year":"2005","unstructured":"Bonardelle D, Benihoud K, Kiger N, Bob\u00e9 P . B lymphocytes mediate Fas-dependent cytotoxicity in MRL\/lpr mice. J Leukocyte Biol 2005; 78: 1052\u20139.","journal-title":"J Leukocyte Biol"},{"key":"BFaps201576_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.cr.7310146","volume":"17","author":"P Yang","year":"2007","unstructured":"Yang P, Li B, Lv P, Zhang Y, Gao XM . Interaction between antigen presenting cells and autoreactive T cells derived from BXSB mice with murine lupus. Cell Res 2007; 17: 556\u201364.","journal-title":"Cell Res"},{"key":"BFaps201576_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.160.1.51","volume":"160","author":"O Chan","year":"1998","unstructured":"Chan O, Shlomchik MJ . A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr\/lpr mice. J Immunol 1998; 160: 51\u20139.","journal-title":"J Immunol"},{"key":"BFaps201576_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1084\/jem.180.4.1295","volume":"180","author":"MJ Shlomchik","year":"1994","unstructured":"Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D . The role of B cells in lpr\/lpr-induced autoimmunity. J Exp Med 1994; 180: 1295\u2013306.","journal-title":"J Exp Med"},{"key":"BFaps201576_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2249.1998.00533.x","volume":"111","author":"T Bourne","year":"1998","unstructured":"Bourne T, Zukowska-Cooper M, Salaman MR, Seifert MH, Isenberg DA . Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38. Clin Exp Immun 1998; 111: 611\u20136.","journal-title":"Clin Exp Immun"},{"key":"BFaps201576_CR8","doi-asserted-by":"publisher","first-page":"e44362","DOI":"10.1371\/journal.pone.0044362","volume":"7","author":"PL Lugar","year":"2012","unstructured":"Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE . Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS One 2012; 7: e44362.","journal-title":"PLoS One"},{"key":"BFaps201576_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12026-010-8189-3","volume":"49","author":"DJ DiLillo","year":"2011","unstructured":"DiLillo DJ, Horikawa M, Tedder TF . B-lymphocyte effector functions in health and disease. Immunol Res 2011; 49: 281\u201392.","journal-title":"Immunol Res"},{"key":"BFaps201576_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/postgradmedj-2011-130364","volume":"88","author":"F McQueen","year":"2012","unstructured":"McQueen F . A B cell explanation for autoimmune disease: the forbidden clone returns. Postgrad Med J 2012; 88: 226\u201333.","journal-title":"Postgrad Med J"},{"key":"BFaps201576_CR11","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s11033-010-0527-y","volume":"38","author":"J Li","year":"2011","unstructured":"Li J, Pan HF, Cen H, Tian J, Ma Y, Tao JH, et al. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus. Mol Biol Rep 2011; 38: 4077\u201381.","journal-title":"Mol Biol Rep"},{"key":"BFaps201576_CR12","first-page":"172","volume":"31","author":"M Nakou","year":"2012","unstructured":"Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to generation of plasma B cells. Clin Exp Rheumatol 2012; 31: 172\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"BFaps201576_CR13","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 2007; 179: 5886\u201396.","journal-title":"J Immunol"},{"key":"BFaps201576_CR14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1189\/jlb.0409268","volume":"86","author":"SO Yoon","year":"2009","unstructured":"Yoon SO, Zhang X, Berner P, Choi YS . IL-21 and IL-10 have redundant roles but differential capacities at different stages of plasma cell generation from human germinal center B cells. J Leukocyte Biol 2009; 86: 1311\u20138.","journal-title":"J Leukocyte Biol"},{"key":"BFaps201576_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228\u201333.","journal-title":"Nat Genet"},{"key":"BFaps201576_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.molimm.2013.05.241","volume":"56","author":"J Luo","year":"2013","unstructured":"Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S . Up-regulation of transcription factor Blimp-1 in systemic lupus erythematosus. Mol Immunol 2013; 56: 574\u201382.","journal-title":"Mol Immunol"},{"key":"BFaps201576_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","volume":"19","author":"M Shapiro-Shelef","year":"2003","unstructured":"Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K . Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003; 19: 607\u201320.","journal-title":"Immunity"},{"key":"BFaps201576_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R . Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8: 22\u201333.","journal-title":"Nat Rev Immunol"},{"key":"BFaps201576_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng0697-161","volume":"16","author":"BH Ye","year":"1997","unstructured":"Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type. Nat Genet 1997; 16: 161\u201370.","journal-title":"Nat Genet"},{"key":"BFaps201576_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.173.2.1158","volume":"173","author":"C Tunyaplin","year":"2004","unstructured":"Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL . Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004; 173: 1158\u201365.","journal-title":"J Immunol"},{"key":"BFaps201576_CR21","first-page":"131","volume":"13","author":"X Zhang","year":"2013","unstructured":"Zhang X, Ing S, Fraser A, Chen M, Khan O, Zakem J, et al. Follicular helper T cells: new insights into mechanisms of autoimmune diseases. Ochsner J 2013; 13: 131\u20139.","journal-title":"Ochsner J"},{"key":"BFaps201576_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12026-008-8023-3","volume":"41","author":"SH Clarke","year":"2008","unstructured":"Clarke SH . Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus. Immunol Res 2008; 41: 203\u201316.","journal-title":"Immunol Res"},{"key":"BFaps201576_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2165\/00063030-200822040-00003","volume":"22","author":"C Ding","year":"2008","unstructured":"Ding C, Foote S, Jones G . B-cell-targeted therapy for systemic lupus erythematosus. Biodrugs 2008; 22: 239\u201349.","journal-title":"Biodrugs"},{"key":"BFaps201576_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2165\/11535420-000000000-00000","volume":"70","author":"RJ Looney","year":"2010","unstructured":"Looney RJ . B cell-targeted therapies for systemic lupus erythematosus. Drugs 2010; 70: 529\u201340.","journal-title":"Drugs"},{"key":"BFaps201576_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.semarthrit.2007.11.003","volume":"38","author":"AT Tieng","year":"2008","unstructured":"Tieng AT, Peeva E . B-cell-directed therapies in systemic lupus erythematosus. Semin Arthritis Rheum 2008; 38: 218\u201327.","journal-title":"Semin Arthritis Rheum"},{"key":"BFaps201576_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4049\/jimmunol.1101563","volume":"189","author":"NA Barnes","year":"2012","unstructured":"Barnes NA, Stephenson S, Cocco M, Tooze RM, Doody GM . BLIMP-1 and STAT3 counter-regulate microRNA-21 during plasma cell differentiation. J Immunol 2012; 189: 253\u201360.","journal-title":"J Immunol"},{"key":"BFaps201576_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00296-013-2896-8","volume":"34","author":"A AlSonbul","year":"2014","unstructured":"AlSonbul A, Al-Mayouf SM . Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus. Rheumatol Int 2014; 34: 529\u201333.","journal-title":"Rheumatol Int"},{"key":"BFaps201576_CR28","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/art.20430","volume":"50","author":"RJ Looney","year":"2004","unstructured":"Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, et al. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab. Arthritis Rheum 2004; 50: 2580\u20139.","journal-title":"Arthritis Rheum"},{"key":"BFaps201576_CR29","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1002\/art.21379","volume":"52","author":"S Werwitzke","year":"2005","unstructured":"Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, et al. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB\u00d7NZW) F1 mouse. Arthritis Rheum 2005; 52: 3629\u201338.","journal-title":"Arthritis Rheum"},{"key":"BFaps201576_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1191\/0961203302lu235oa","volume":"11","author":"A Anand","year":"2002","unstructured":"Anand A, Dean GS, Quereshi K, Isenberg DA, Lydyard PM . Characterization of CD3+ CD4\u2212CD8\u2212(double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus 2002; 11: 493\u2013500.","journal-title":"Lupus"},{"key":"BFaps201576_CR31","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1182\/blood-2006-04-020610","volume":"108","author":"P Bob\u00e9","year":"2006","unstructured":"Bob\u00e9 P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK . Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL\/lpr mice. Blood 2006; 108: 3967\u201375.","journal-title":"Blood"},{"key":"BFaps201576_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/cimm.1999.1570","volume":"197","author":"CA Jonsson","year":"1999","unstructured":"Jonsson CA, Erlandsson M, Svensson L, M\u00f6lne J, Carlsten H . Mycophenolate mofetil ameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr\/lpr mice. Cell Immunol 1999; 197: 136\u201344.","journal-title":"Cell Immunol"},{"key":"BFaps201576_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaut.2012.05.010","volume":"39","author":"IM Mumtaz","year":"2012","unstructured":"Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY, et al. Bone marrow of NZB\/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity. J Autoimmun 2012; 39: 180\u20138.","journal-title":"J Autoimmun"},{"key":"BFaps201576_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/intimm\/dxg102","volume":"15","author":"K Murata","year":"2003","unstructured":"Murata K, Inami M, Hasegawa A, Kubo S, Kimura M, Yamashita M, et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol 2003; 15: 987\u201392.","journal-title":"Int Immunol"},{"key":"BFaps201576_CR35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.4049\/jimmunol.1100765","volume":"188","author":"K Radulovic","year":"2012","unstructured":"Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, et al. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J Immunol 2012; 188: 2001\u201313.","journal-title":"J Immunol"},{"key":"BFaps201576_CR36","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.4049\/jimmunol.1301173","volume":"191","author":"KE Block","year":"2013","unstructured":"Block KE, Huang H . The cellular source and target of IL-21 in K\/BxN autoimmune arthritis. J Immunol 2013; 191: 2948\u201355.","journal-title":"J Immunol"},{"key":"BFaps201576_CR37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0807309106","volume":"106","author":"JA Bubier","year":"2009","unstructured":"Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse HC, et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A 2009; 106: 1518\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201576_CR38","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.4049\/jimmunol.1301559","volume":"191","author":"B Rodr\u00edguez-Bayona","year":"2013","unstructured":"Rodr\u00edguez-Bayona B, Ramos-Amaya A, L\u00f3pez-Blanco R, Campos-Caro A, Brieva JA . STAT-3 activation by differential cytokines is critical for human in vivo\u2013generated plasma cell survival and Ig secretion. J Immunol 2013; 191: 4996\u20135004.","journal-title":"J Immunol"},{"key":"BFaps201576_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nri1688","volume":"5","author":"WJ Leonard","year":"2005","unstructured":"Leonard WJ, Spolski R . Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 2005; 5: 688\u201398.","journal-title":"Nat Rev Immunol"},{"key":"BFaps201576_CR40","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4049\/jimmunol.1201678","volume":"190","author":"BB Ding","year":"2013","unstructured":"Ding BB, Bi E, Chen H, Yu JJ, Ye BH . IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells. J Immunol 2013; 190: 1827\u201336.","journal-title":"J Immunol"},{"key":"BFaps201576_CR41","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1084\/jem.20102065","volume":"208","author":"SK Lee","year":"2011","unstructured":"Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, Marshall JL, et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J Exp Med 2011; 208: 1377\u201388.","journal-title":"J Exp Med"},{"key":"BFaps201576_CR42","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1128\/JVI.00063-13","volume":"87","author":"MA Rasheed","year":"2013","unstructured":"Rasheed MA, Latner DR, Aubert RD, Gourley T, Spolski R, Davis CW, et al. Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. J Virol 2013; 87: 7737\u201346.","journal-title":"J Virol"},{"key":"BFaps201576_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.humimm.2012.11.019","volume":"74","author":"Z Zhou","year":"2012","unstructured":"Zhou Z, Li A, Wang Z, Pei F, Xia Q, Liu G, et al. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice. Hum Immunol 2012; 74: 297\u2013301.","journal-title":"Hum Immunol"},{"key":"BFaps201576_CR44","first-page":"827480","volume":"2012","author":"J Ma","year":"2012","unstructured":"Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol 2012; 2012: 827480.","journal-title":"Clin Dev Immunol"},{"key":"BFaps201576_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev.immunol.21.120601.141138","volume":"21","author":"KL Calame","year":"2003","unstructured":"Calame KL, Lin KI, Tunyaplin C . Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205\u201330.","journal-title":"Annu Rev Immunol"},{"key":"BFaps201576_CR46","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004; 173: 5361\u201371.","journal-title":"J Immunol"},{"key":"BFaps201576_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51\u201362.","journal-title":"Immunity"},{"key":"BFaps201576_CR48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef M, Calame K . Regulation of plasma-cell development. Nat Rev Immunol 2005; 5: 230\u201342.","journal-title":"Nat Rev Immunol"},{"key":"BFaps201576_CR49","doi-asserted-by":"publisher","first-page":"e23900","DOI":"10.1371\/journal.pone.0023900","volume":"6","author":"JC Garaud","year":"2011","unstructured":"Garaud JC, Schickel JN, Blaison G, Knapp AM, Dembele D, Ruer-Laventie J, et al. B cell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus. PLoS One 2011; 6: e23900.","journal-title":"PLoS One"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201576","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T01:22:50Z","timestamp":1692062570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFaps201576"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.76","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]},"assertion":[{"value":"11 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}